Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Epilim Chrono 500 tablets
0408010W0BBALA2
|
Epilim | Sodium valproate | Central Nervous System | 85,776 |
|
Epilim Chrono 300 tablets
0408010W0BBAKA1
|
Epilim | Sodium valproate | Central Nervous System | 61,564 |
|
Epilim Chrono 200 tablets
0408010W0BBAJAZ
|
Epilim | Sodium valproate | Central Nervous System | 51,897 |
|
Sodium valproate 500mg gastro-resistant tablets
0408010W0AAADAD
|
Sodium valproate | Sodium valproate | Central Nervous System | 50,451 |
|
Sodium valproate 200mg gastro-resistant tablets
0408010W0AAACAC
|
Sodium valproate | Sodium valproate | Central Nervous System | 49,947 |
|
Epilim 200 gastro-resistant tablets
0408010W0BBABAC
|
Epilim | Sodium valproate | Central Nervous System | 33,832 |
|
Epilim 500 gastro-resistant tablets
0408010W0BBACAD
|
Epilim | Sodium valproate | Central Nervous System | 33,325 |
|
Sodium valproate 500mg modified-release tablets
0408010W0AAA2A2
|
Sodium valproate | Sodium valproate | Central Nervous System | 30,132 |
|
Epilim 200mg/5ml liquid
0408010W0BBADAA
|
Epilim | Sodium valproate | Central Nervous System | 26,082 |
|
Sodium valproate 300mg modified-release tablets
0408010W0AAA1A1
|
Sodium valproate | Sodium valproate | Central Nervous System | 22,378 |
|
Sodium valproate 200mg/5ml oral solution sugar free
0408010W0AAAAAA
|
Sodium valproate | Sodium valproate | Central Nervous System | 20,438 |
|
Sodium valproate 200mg modified-release tablets
0408010W0AAAZAZ
|
Sodium valproate | Sodium valproate | Central Nervous System | 16,060 |
|
Sodium valproate 100mg tablets
0408010W0AAABAB
|
Sodium valproate | Sodium valproate | Central Nervous System | 15,267 |
|
Epilim 100mg crushable tablets
0408010W0BBAAAB
|
Epilim | Sodium valproate | Central Nervous System | 10,702 |
|
Sodium valproate 200mg/5ml oral solution
0408010W0AAAEAE
|
Sodium valproate | Sodium valproate | Central Nervous System | 8,399 |
|
Sodium valproate 300mg modified-release capsules
0408010W0AABRBR
|
Sodium valproate | Sodium valproate | Central Nervous System | 5,126 |
|
Episenta 300mg modified-release capsules
0408010W0BIACBR
|
Episenta | Sodium valproate | Central Nervous System | 4,257 |
|
Epilim 200mg/5ml syrup
0408010W0BBAEAE
|
Epilim | Sodium valproate | Central Nervous System | 3,809 |
|
Epilim Chronosphere MR 500mg granules sachets
0408010W0BBAMBS
|
Epilim | Sodium valproate | Central Nervous System | 3,475 |
|
Epilim Chronosphere MR 100mg granules sachets
0408010W0BBAPBW
|
Epilim | Sodium valproate | Central Nervous System | 2,782 |
|
Epilim Chronosphere MR 1000mg granules sachets
0408010W0BBASBT
|
Epilim | Sodium valproate | Central Nervous System | 2,113 |
|
Epilim Chronosphere MR 250mg granules sachets
0408010W0BBAQBX
|
Epilim | Sodium valproate | Central Nervous System | 1,641 |
|
Episenta 500mg modified-release granules sachets
0408010W0BIADBS
|
Episenta | Sodium valproate | Central Nervous System | 1,496 |
|
Episenta 1000mg modified-release granules sachets
0408010W0BIAEBT
|
Episenta | Sodium valproate | Central Nervous System | 1,294 |
|
Episenta 150mg modified-release capsules
0408010W0BIABBQ
|
Episenta | Sodium valproate | Central Nervous System | 1,210 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.